Representatives from VC funds and investment vehicles of major companies actively investing in Life Sciences in the CEE region will discuss current trends and share their recommendations for early-stage companies.
The panelists are:
- David Flores, CEO, BioCentury
- Ingrid Kelly, Partner, xista science ventures
- Marek Tyl, Business Development Manager Europe, Eppendorf SE
- John Murray, VP Global Business Development, SanaClis
Panel moderator: Magdalena Marciniak, Advisor, i&i Biotech Fund
For whole profiles see the „Our speakers“ section.